Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase Cα

Molecular Pharmacology

Volumn 57, Issue 6, 2000, Pages 1224-1234

  Gschwend, Jürgen E ^a,b   Fair, William R ^a   Powell, C Thomas ^a,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF ULM   (Germany)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRYOSTATIN 1; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PHOSPHORYLATION; PRIORITY JOURNAL; PROSTATE CANCER;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOLOGICAL TRANSPORT; CARCINOGENS; CELL DIVISION; DOWN-REGULATION; ENZYME ACTIVATION; HUMANS; ISOENZYMES; LACTONES; MACROLIDES; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; PROTO-ONCOGENE PROTEINS C-RAF; SUBCELLULAR FRACTIONS; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

EID: 0034042882     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. App H, Hazan R, Zilberstein A, Ullrich A, Schlessinger J and Rapp U (1991) Epidermal growth factor (EGF) stimulates association and kinase activity of Raf-1 with the EGF receptor. Mol Cell Biol 11:913-919.
2. Blagosklonny MV (1998) The mitogen-activated protein kinase pathway mediates growth arrest or E1A-dependent apoptosis in SKBR3 human breast cancer cells. Int J Cancer 78:511-517.
3. Blumberg PM and Pettit GR (1992) The bryostatins, a family of protein kinase C activators with therapeutic potential, in New Leads and Targets in Drug Research (Krogsgaard-Larsen P, Brogger P, Christensen S and Kofod H eds) pp 273-285, Munksgaard International Publishers, Ltd, Copenhagen.
4. Cai H, Smola U, Wixler V, Eisenmann-Tappe I, Diaz-Meco MT, Moscat J, Rapp U and Cooper GM (1997) Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase. Mol Cell Biol 17:732-741.
5. Chakravarthy BR, Whitfield JF and Durkin JP (1994) Inactive membrane protein kinase Cs: A possible target for receptor signalling. Biochem J 304:809-816.
6. Chou MM, Hou W, Johnson J, Graham LK, Lee MH, Chen CS, Newton AC, Schaffhausen BS and Toker A (1998) Regulation of protein kinase C zeta by PI 3-kinase and PDK-1. Curr Biol 8:1069-1077.
7. Clemens MJ, Trayner I and Menaya J (1992) The role of protein kinase C isozymes in the regulation of cell proliferation and differentiation. J Cell Sci 103:881-887.
8. Day ML, Zhao X, Wu S, Swanson PE and Humphrey PA (1994) Phorbol esterinduced apoptosis is accompanied by NGFI-A and c-fos activation in androgensensitive prostate cancer cells. Cell Growth Differ 5:735-741.
9. Diaz-Meco MT, Municio MM, Frutos S, Sanchez P, Lozano J, Sanz L and Moscat J (1996) The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C. Cell 86:777-786.
10. Ebinu JO, Bottorff DA, Chan EY, Stang SL, Dunn RJ and Stone JC (1998) RasGRP, a Ras guanyl nucleotide-releasing protein with calcium-and diacylglycerol-binding motifs. Science (Wash DC) 280:1082-1086.
11. Finkenzeller G, Marme D and Hug H (1990) Sequence of human protein kinase C α. Nucleic Acids Res 18:2183.
12. Gavrieli Y, Sherman Y and Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
13. Gossen M and Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547-5551.
14. Gschwend JE, Fair WR and Powell CT (1997) Evaluation of the tetracycline-repressible transactivator system for inducible gene expression in human prostate cancer cell lines. Prostate 33:166-176.
15. Horoszewics JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA and Murphy GP (1983) LNCaP model of human prostatic cancer. Cancer Res 43:1809-1818.
16. 2+-activated and phospholipid-dependent protein kinase. Proc Natl Acad Sei USA 83:8535-8539.
17. Huwiler A, Fabbro D and Pfeilschifter J (1994) Comparison of different tumour promoters and bryostatin 1 on protein kinase C activation and down-regulation in rat renal mesangial cells. Biochem Pharmacol 48:689-700.
18. Isakov N, Galron D, Mustelin T, Pettit GR and Altman A (1993) Inhibition of phorbol ester-induced T cell proliferation by bryostatin is associated with rapid degradation of protein kinase. J Immunol 150:1195-1204.
19. Jin L-W, Inaba K and Saitoh T (1992) The involvement of protein kinase C in activation-induced cell death in T-cell hybridoma. Cell Immunol 144:217-227.
20. Kroemer G, Dallaporta B and Resche-Rigon M (1998) The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 60:619-642.
21. Landis SH, Murray T, Bolden S and Wingo PA (1999) Cancer statistics, 1999 (see comments). CA Cancer J Clin 49:8-31.
22. Liu Y, Martindale JL, Gorospe M and Holbrook NJ (1996) Regulation of p21WAF1/ CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res 56:31-35.
23. Marais R, Light Y, Mason C, Paterson H, Olson MF and Marshall CJ (1998) Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. Science (Wash DC) 280:109-112. [Published erratum appears in Science (Wash DC) (1998) 280:987.]
24. Nishizuka Y (1995) Protein kinase C and lipid signalling for sustained cellular responses. FASEB J 9:484-496.
25. Powell CT, Brittis NJ, Stec D, Hug H, Heston WD and Fair WR (1996) Persistent membrane translocation of protein kinase C alpha during 12-O-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells. Cell Growth Differ 7:419-428.
26. Ravi RK, McMahon M, Yangang Z, Williams JR, Dillehay LE, Nelkin BD and Mabry M (1999) Raf-1-induced cell cycle arrest in LNCaP human prostate cancer cells. J Cell Biochem 72:458-469.
27. Roehm NW, Rodgers GH, Hatfield SM and Glasebrook AL (1991) An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Methods 142:257-265.
28. Ron D and Kazanietz MG (1999) New insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J 13:1658-1676.
29. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning: A Laboratory Manual Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
30. Schonwasser DC, Marais RM, Marshall CJ and Parker PJ (1998) Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol Cell Biol 18:790-798.
31. Seger R and Krebs EG (1995) The MAPK signaling cascade. FASEB J 9:726-735.
32. Slaga TJ (1983) Host factors in the susceptibility of mice to tumour initiating and promoting agents. IARC Sci Publ 51:257-273.
33. Szallasi Z, Denning MF, Smith CB, Dlugosz AA, Yuspa SH, Pettit GR and Blumberg PM (1994a) Bryostatin 1 protects protein kinase C-δ from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation. Mol Pharmacol 46:840-850.
34. Szallasi Z, Du L, Levine R, Lewin NE, Nguyen PN, Williams MD, Pettit GR and Blumberg PM (1996) The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: Dissociation of activities using 26-epi-bryostatin 1. Cancer Res 56:2105-2111.
35. Szallasi Z, Smith CB, Pettit GR and Blumberg PM (1994b) Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts. J Biol Chem 269:2118-2124.
36. Ueda Y, Hirai S, Osada S, Suzuki A, Mizuno K and Ohno S (1996) Protein kinase C δ activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J Biol Chem 271:23512-23519.
37. Westin P, Stattin P, Damber J-E and Bergh A (1995) Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors. Am J Pathol 146:1368-1375.
38. Woods D, Parry D, Cherwinski H, Bosch E, Lees E and McMahon M (1997) Rafinduced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol 17:5598-5611.
39. Young CYF, Murtha PE and Zhang J (1994) Tumor-promoting phorbol ester-induced cell death and gene expression in a human prostate adenocarcinoma cell line. Oncol Res 6:203-210.
40. Zhao X, Gschwend JE, Powell CT, Foster RG, Day KC and Day ML (1997) Retinoblastoma protein-dependent growth signal conflict and caspase activity are required for protein kinase C-signaled apoptosis of prostate epithelial cells. J Biol Chem 272:22751-22757.